Epigral Ltd · NSE:EPIGRAL

Epigral — Meghmani Finechem — Investor Presentation (August 2022)

27 slides from Epigral's investor presentation, Aug 8, 2022

  1. Slide 1: Meghmani Finechem Limited

    Meghmani Finechem Limited FL Yo ur esse n t i a l s. Our ex p e rt i se . Registered Office : "Meg hmani House", 8/ h. Safal Profita ire, Corporate Road, Prahladnagar, Ahmedabad - 380 015. Gujarat. INDIA. I T: +91 79 2970 9600 / 7176 1000 E: helpdesk@meghmanifinechem.com I CIN: L24100GJ2007PLC051717

  2. Slide 2: Corporate Presentation

    Meghmani Finechem Limited Corporate Presentation

  3. Slide 3: Disclaimer

    Disclaimer This presentation and the accompanying slides (the “Presentation”), which have been prepared by Meghmani Finechem Limited (the “Company”) solely for the information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities and shall

  4. Slide 4: MFL Plant Video

    MFL Plant Video 3 | MEGHMANI FINECHEM LIMITED

  5. Slide 5: Company Overview

    Company Overview Founded: 2007 32% 29% 5 Year Revenue CAGR (FY22) 5 Year EBITDA CAGR (FY22) Employees: 850+ 1.3x 29% Debt to Equity (FY22) ROCE (FY22) Capacity: Chlor-Alkali# – 315 KTPA Derivatives# – 190 KTPA Revenue from operations (₹ Cr) 5,000 Certified: 1551 Responsible Care Certificate 829 598

  6. Slide 6: What are we into

    What are we into ESG Focus Our Business o Leading producer of Chlor- o Strong focus on sustainability - alkali products and value awarded with the ‘Responsible added derivatives Care’ Logo by ICC Strategic Location Competitive Advantage o State of the art manufacturing o Domestically produced ECH, C

  7. Slide 7: Our Evolution

    Our Evolution FY2022 FY2021 FY2020 Listed as an independent FY2018 Commissioned and increased entity on 18th August 2021 FY2017 Commissioned capacity Announced FY2015 Announced CMS - 50 KTPA Caustic Soda - 294 KTPA expansion in new Chlorotoluene Commissioned FY2010 KOH – expansions Announced expansi

  8. Slide 8: Driven by Strong Values

    Driven by Strong Values • Maintaining high standards on transparency and disclosures Trust with all our stakeholders We enhance diverse employee engagement for increased o Caring for the environment and productivity & creativity and are Diversity Integrity the communities in which we an equal opport

  9. Slide 9: MFL Evolving to value added specialty products

    MFL Evolving to value added specialty products Fully Integrated Product Portfolio High Value Products Chlorotoluene & value chain ECH ECH Import Substitution – Make in India Chlor-Alkali H202 H202 CPVC CPVC Diversified End User Industries Chlorine Hydrogen CMS CMS Sole Manufacturer of ECH in India C

  10. Slide 10: Fully Integrated Complex

    Fully Integrated Complex 9 | MEGHMANI FINECHEM LIMITED

  11. Slide 11: Competitive Strength

    Competitive Strength Well Invested Infrastructure Well established brand o State of the art manufacturing facility o MFL is a known brand in Indian chemical market o Strategic location with close connectivity to o Serving domestic customers for last 12 Yrs ports and raw material availability. o Pan

  12. Slide 12: Catering to High Growth Industries

    Catering to High Growth Industries Increased market potential & higher growth exposure Refinery Paper & Pulp Fluoropolymers Soap & Detergents Textiles Dyes & Pigment Pharmaceuticals Agrochemicals Alumina PU Foams Paints PTFE Pipes Heat Resistant Pipes Refrigerant Gas Water Treatment Electronics The

  13. Slide 13: Levers of Future Growth

    Levers of Future Growth Manufacturing Plant Capacity (‘000 TPA) 106 Q2 FY23 60 50 50 294 30 21 Caustic Soda Hydrogen Peroxide Chloromethanes Caustic Potash Epichlorohydrin CPVC Chlorotoluene & its Q2FY21* Q2FY20* Q1FY23* Q2FY23 value chain Q4FY24 Expected Commissioning , * Commissioning date 12 | ME

  14. Slide 14: Transitioning to Value added products

    Transitioning Transitioning to Value to Value added added products Specialty Chemicals Chlor-Alkali – 74% Chlor-Alkali–– Chlor-Alkali < 40% 40% FY2022 Derivative FY2027E ₹1,551 Cr s ₹5,000 Cr 26% Derivatives & Derivatives & Specialty Specialty & Chemicals –Derivatives 68% Chemicals Specialty 60% Che

  15. Slide 15: Product Portfolio – Chlor-Alkali

    Product Portfolio – Chlor-Alkali Caustic Soda (NaOH) Caustic Potash (KOH)  India’s NaOH Requirement: 4,200 KTPA  India’s KOH Requirement: 91 KTPA  Demand CAGR: ~ 8%  Demand CAGR: ~ 8% Alumina Textile Chemicals Agrochemicals API o We are 4th largest producer in India o We are 3rd largest producer

  16. Slide 16: Product Portfolio – Derivative products

    Product Portfolio – Derivative products Chloromethanes (CMS) Hydrogen Peroxide (H2O2)  India’s CMS Requirement: 517 KTPA  India’s H2O2 Requirement: 328 KTPA  Demand CAGR: ~ 12%  Demand CAGR: ~ 10% Solvent in Pharma PTFE Pipes Refrigerant Gas Paper & pulp Textile Chemicals o We are 5th largest pr

  17. Slide 17: New Product Portfolio – Specialty Chemicals

    New Product Portfolio – Specialty Chemicals CPVC Resin Epichlorohydrin (ECH)  India’s CPVC Requirement: 140 KTPA  India’s ECH Requirement: 80 KTPA  Demand CAGR: ~ 13%  Demand CAGR: ~ 15% Wind mill Automobile Adhesives Pipes and Fixtures o Largest producer in India o 1st company in India to produ

  18. Slide 18: Chlorotoluene & its value chain - Specialty Chemicals

    Chlorotoluene & its value chain - Specialty Chemicals Project Details Rationale o Capex for the project will be ₹ 180 Cr and o Foundation for the next phase of growth in expected revenue of Rs. 300 Cr Specialty Chemicals o Expected commissioning date: Q4FY24 o Chlorine is captive a raw material - in

  19. Slide 19: Research & Development Centre

    Research & Development Centre Project Details Rationale o Capex for the project will be ₹ 25 Cr o R&D center will be used for creating further molecules for Chlorotoluene and other new molecules, which will be intermediates for o A step towards strengthening presence in pharmaceutical and agrochemic

  20. Slide 20: Professional Management Team

    Professional Management Team Mr. Maulik Patel Mr. Kaushal Soparkar Chairman & Managing Managing Director Director Mr. Yash Chitnis Mr. Sanjay Jain Mr. Naresh Agarwal Mr. Vijay Vasudeva Sales Head – Chief Financial Sales Head – Chlor- Head of Operations Derivatives & Specialty Officer Chemicals Alkal

  21. Slide 21: Focused on ESG

    Focused on ESG ENVIRONMENT o Focused on using best technology to manage critical resources, to moderate the consumption of energy and natural resources and drive operations efficiently o Focus is to manufacture more from less, basis for environment responsibility o Entered in JV to set up 18.34 MW W

  22. Slide 22: Growth Strategy

    Growth Strategy Forward & Backward Opportunities in high New Value Chains: Achieving economies Integration: growth sectors: of scale: o Scale up capacities in o Explore opportunities o Expand chemistry o Optimising existing existing products in various sectors expertise to enter complex o New value

  23. Slide 23: Financial Performance – P&L

    Financial Performance – P&L Revenue from operations (₹ Cr) EBITDA (₹ Cr & %) PAT (₹ Cr & %) CAGR 32% 44% 26% 25% 43% 1,551 509 253 32% 32% 33% 18% 183 16% 155 12% 312 829 255 261 710 112 598 611 194 101 FY2018 FY2019 FY2020 FY2021 FY2022 FY2018 FY2019 FY2020 FY2021 FY2022 FY2018 FY2019 FY2020 FY2021

  24. Slide 24: Balance Sheet Ratios

    Balance Sheet Ratios ROCE (%) ROE (%) Debt/EBITDA (x) 38% 36% 35% 36% 36% 2.7 29% 2.1 1.9 21% 16% 16% 1.3 15% 0.3 FY2018 FY2019 FY2020 FY2021 FY2022 FY2018 FY2019 FY2020 FY2021 FY2022 FY2018 FY2019 FY2020 FY2021 FY2022 23 | MEGHMANI FINECHEM LIMITED

  25. Slide 25: Historic Income Statement

    Historic Income Statement Particulars (₹ Cr) FY18 FY19 FY20 FY21 FY22 Total Revenue 602 720 613 831 1,555 Gross Profit* 335 431 300 407 716 Gross Margin (%) 56% 61% 49% 49% 46% EBITDA 255 312 194 261 510 EBITDA Margin (%) 43% 44% 32% 32% 33% Depreciation 55 54 44 74 86 Finance Cost 9 25 11 29 44 PBT

  26. Slide 26: Historic Balance Sheet

    Historic Balance Sheet Assets (₹ Cr) FY20 FY21 FY22 Liabilities (₹ Cr) FY20 FY21 FY22 Fixed Assets 1,131 1,228 1,657 Share Capital 42 42 42 Financial Assets 4 10 8 Reserves & Surplus 542 643 684 Other Non-current Assets 5 29 11 Long-Term Borrowings 418 340 557 Inventories 48 54 154 Redeemable Prefer

  27. Slide 27: About Us and Investor Contact

    About Us and Investor Contact Corporate Office Manufacturing Site Regional Office Regional Office “Meghmani House”, B/h Safal CH/1 and CH/2, GIDC Industrial Regus Mid-Town 1st Floor, 303-B, Alpha, Main Street, Profitaire, Corporate Road, Estate, Dahej, Tal. Vagra, Dist. 101, Mid Town Plaza, Hiranand

Meghmani Finechem — Investor Presentation (August 2022) on 6ix